Purpose: To evaluate the role of intravitreal Triamcinolone (TA) in the early management of Coats’ disease with or without trans-scleral drainage. Methods: Retrospective, interventional case series. Fifteen consecutive cases with Coats’ disease were managed with 4mg/0.1ml intravitreal Triamcinolone injection on presentation and were followed up for a minimum duration of one year. Additional management strategies included...

Read More